Neuromyelitis Optica Spectrum Disorder
·MeSH: Neuromyelitis Optica
4 drugs in development·4 companies·1 clinical trial
Drug Pipeline by Phase
Approved(3)
Phase 4(1)
| Drug | Company |
|---|---|
| Eculizumab administration | Valneva SE (VALN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Neuromyelitis Optica Spectrum Disorder?
BioSniper tracks 4 drugs in development for Neuromyelitis Optica Spectrum Disorder across 4 companies.
How many clinical trials target Neuromyelitis Optica Spectrum Disorder?
There are 1 clinical trial targeting Neuromyelitis Optica Spectrum Disorder tracked by BioSniper.
Deep-dive into Neuromyelitis Optica Spectrum Disorder
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis